Report Detail

Chemical & Material Global Oligonucleotides Market Growth 2019-2024

  • RnM3391593
  • |
  • 07 May, 2019
  • |
  • Global
  • |
  • 161 Pages
  • |
  • LPI(LP Information)
  • |
  • Chemical & Material

Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.

Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.

Oligonucleotide is widely used in Research, Pharmaceutical and Diagnostic. The most proportion of Oligonucleotide used in Research, and the revenue in 2018 is 409.97 M USD. Moreover, increase in focus on targeted gene therapies has revolutionized treatment of incurable conditions caused by genetic mutations. Increase in demand for sequencing applications by clinical, diagnostic, academic, and drug development is witnessed by manufactures.
North America is the largest customer of Oligonucleotide, with a revenue market share nearly 37.51% in 2018. Europe is the second largest consumer of Oligonucleotide, enjoying revenue market share nearly 30.5% in 2018. Asian countries are recognized as the fastest adopters of sequencing, array technology, and PCR products due to rapid progress in genomics studies and the healthcare sector. Japan and China are considered as the most attractive markets with respect to expansion and growth opportunities present in these countries. In addition, changing economic scenario, along with high investments in healthcare, life science-related research programs, and genetics, has encouraged global players to enter the Asia Pacific market, thus aiding its growth.

According to this study, over the next five years the Oligonucleotides market will register a 10.5% CAGR in terms of revenue, the global market size will reach US$ 1489.5 million by 2024, from US$ 905.9 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oligonucleotides business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotides market by product type, application, key manufacturers and key regions and countries.

This study considers the Oligonucleotides value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
DNA Oligos
RNA Oligos
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Pharmaceutical
Research
Diagnostic

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Oligonucleotides consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Oligonucleotides market by identifying its various subsegments.
Focuses on the key global Oligonucleotides manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oligonucleotides with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Oligonucleotides submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Oligonucleotides Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Oligonucleotides Consumption 2014-2024
        • 2.1.2 Oligonucleotides Consumption CAGR by Region
      • 2.2 Oligonucleotides Segment by Type
        • 2.2.1 DNA Oligos
        • 2.2.2 RNA Oligos
      • 2.3 Oligonucleotides Consumption by Type
        • 2.3.1 Global Oligonucleotides Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Oligonucleotides Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Oligonucleotides Sale Price by Type (2014-2019)
      • 2.4 Oligonucleotides Segment by Application
        • 2.4.1 Pharmaceutical
        • 2.4.2 Research
        • 2.4.3 Diagnostic
      • 2.5 Oligonucleotides Consumption by Application
        • 2.5.1 Global Oligonucleotides Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Oligonucleotides Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Oligonucleotides Sale Price by Application (2014-2019)

      3 Global Oligonucleotides by Manufacturers

      • 3.1 Global Oligonucleotides Sales Market Share by Manufacturers
        • 3.1.1 Global Oligonucleotides Sales by Manufacturers (2017-2019)
        • 3.1.2 Global Oligonucleotides Sales Market Share by Manufacturers (2017-2019)
      • 3.2 Global Oligonucleotides Revenue Market Share by Manufacturers
        • 3.2.1 Global Oligonucleotides Revenue by Manufacturers (2017-2019)
        • 3.2.2 Global Oligonucleotides Revenue Market Share by Manufacturers (2017-2019)
      • 3.3 Global Oligonucleotides Sale Price by Manufacturers
      • 3.4 Global Oligonucleotides Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
        • 3.4.1 Global Oligonucleotides Manufacturing Base Distribution and Sales Area by Manufacturers
        • 3.4.2 Players Oligonucleotides Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Oligonucleotides by Regions

      • 4.1 Oligonucleotides by Regions
        • 4.1.1 Global Oligonucleotides Consumption by Regions
        • 4.1.2 Global Oligonucleotides Value by Regions
      • 4.2 Americas Oligonucleotides Consumption Growth
      • 4.3 APAC Oligonucleotides Consumption Growth
      • 4.4 Europe Oligonucleotides Consumption Growth
      • 4.5 Middle East & Africa Oligonucleotides Consumption Growth

      5 Americas

      • 5.1 Americas Oligonucleotides Consumption by Countries
        • 5.1.1 Americas Oligonucleotides Consumption by Countries (2014-2019)
        • 5.1.2 Americas Oligonucleotides Value by Countries (2014-2019)
      • 5.2 Americas Oligonucleotides Consumption by Type
      • 5.3 Americas Oligonucleotides Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Oligonucleotides Consumption by Countries
        • 6.1.1 APAC Oligonucleotides Consumption by Countries (2014-2019)
        • 6.1.2 APAC Oligonucleotides Value by Countries (2014-2019)
      • 6.2 APAC Oligonucleotides Consumption by Type
      • 6.3 APAC Oligonucleotides Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Oligonucleotides by Countries
        • 7.1.1 Europe Oligonucleotides Consumption by Countries (2014-2019)
        • 7.1.2 Europe Oligonucleotides Value by Countries (2014-2019)
      • 7.2 Europe Oligonucleotides Consumption by Type
      • 7.3 Europe Oligonucleotides Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Oligonucleotides by Countries
        • 8.1.1 Middle East & Africa Oligonucleotides Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Oligonucleotides Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Oligonucleotides Consumption by Type
      • 8.3 Middle East & Africa Oligonucleotides Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Oligonucleotides Distributors
      • 10.3 Oligonucleotides Customer

      11 Global Oligonucleotides Market Forecast

      • 11.1 Global Oligonucleotides Consumption Forecast (2019-2024)
      • 11.2 Global Oligonucleotides Forecast by Regions
        • 11.2.1 Global Oligonucleotides Forecast by Regions (2019-2024)
        • 11.2.2 Global Oligonucleotides Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Oligonucleotides Forecast by Type
      • 11.8 Global Oligonucleotides Forecast by Application

      12 Key Players Analysis

      • 12.1 Integrated DNA Technologies
        • 12.1.1 Company Details
        • 12.1.2 Oligonucleotides Product Offered
        • 12.1.3 Integrated DNA Technologies Oligonucleotides Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Integrated DNA Technologies News
      • 12.2 Agilent
        • 12.2.1 Company Details
        • 12.2.2 Oligonucleotides Product Offered
        • 12.2.3 Agilent Oligonucleotides Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Agilent News
      • 12.3 Sigma-aldrich
        • 12.3.1 Company Details
        • 12.3.2 Oligonucleotides Product Offered
        • 12.3.3 Sigma-aldrich Oligonucleotides Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Sigma-aldrich News
      • 12.4 Eurofins Genomics
        • 12.4.1 Company Details
        • 12.4.2 Oligonucleotides Product Offered
        • 12.4.3 Eurofins Genomics Oligonucleotides Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Eurofins Genomics News
      • 12.5 L.G.C Biosearch Technologies
        • 12.5.1 Company Details
        • 12.5.2 Oligonucleotides Product Offered
        • 12.5.3 L.G.C Biosearch Technologies Oligonucleotides Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 L.G.C Biosearch Technologies News
      • 12.6 Eurogentec S.A
        • 12.6.1 Company Details
        • 12.6.2 Oligonucleotides Product Offered
        • 12.6.3 Eurogentec S.A Oligonucleotides Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Eurogentec S.A News
      • 12.7 Nitto Denko Avecia Inc
        • 12.7.1 Company Details
        • 12.7.2 Oligonucleotides Product Offered
        • 12.7.3 Nitto Denko Avecia Inc Oligonucleotides Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Nitto Denko Avecia Inc News
      • 12.8 GenScript
        • 12.8.1 Company Details
        • 12.8.2 Oligonucleotides Product Offered
        • 12.8.3 GenScript Oligonucleotides Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 GenScript News
      • 12.9 BBI Life Sciences
        • 12.9.1 Company Details
        • 12.9.2 Oligonucleotides Product Offered
        • 12.9.3 BBI Life Sciences Oligonucleotides Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 BBI Life Sciences News
      • 12.10 GeneDesign
        • 12.10.1 Company Details
        • 12.10.2 Oligonucleotides Product Offered
        • 12.10.3 GeneDesign Oligonucleotides Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 GeneDesign News
      • 12.11 TriLink BioTechnologies
      • 12.12 SGS DNA
      • 12.13 LC Sciences
      • 12.14 Twist Bioscience
      • 12.15 Creative Biogene
      • 12.16 General Biosystems

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Oligonucleotides . Industry analysis & Market Report on Oligonucleotides is a syndicated market report, published as Global Oligonucleotides Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Oligonucleotides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,873.10
      4,309.65
      5,746.20
      3,374.52
      5,061.78
      6,749.04
      574,583.40
      861,875.10
      1,149,166.80
      304,182.60
      456,273.90
      608,365.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report